Gregory J. Smith Email & Phone Number

Boston South

Cardiac Amyloidosis SpecialistKey Achievements:• Launched the first Selective Stabilizer for ATTR-CM (Tafamidis) throughout the Boston and Rhode Island area.• Aligning internal and external stakeholders across the Care Continuum for diagnosis, treatment of Cardiac Amyloidosis with COE’s and Strategic Accounts to drive brand awareness and revenue.• Successfully launched Cardiac Amyloidosis Suspect & Detect platform with COE’s and key accounts resulting in targeted clinical and business results.• Advancing education through partnerships with COE’s (BWH & BMC) for Cardiac Amyloidosis preceptorships

New England

New England

New England

• Accountable for Sucampo business in medical centers throughout the New England area.• Developed relationships with Key Opinion Leaders to secure better exposure for promoted products.• Won consecutive monthly sales contest for sales growth for 4 of 8 months.• Delivered product presentations and education sessions on evolving product advancements.• Continually expanded sales network among physicians, nurses, social workers, pharmacies and health care agencies

• Led business development in Oncology / Hematology hospital and office based accounts in RI, MA and CT.• Developed Key Opinion Leaders to share clinical experience with Gleevec.• Ranked #1 out of 10 in District for year end 2006.• Ranked 8th / 24 in Region and 28th / 104 in Nation for year end 2006.• Appointed to 2004 incentive task team to provide feedback to management regarding creative implementation of sales incentive plan.• Provided feedback to director of sales prior to introduction of key account strategy rollout to field force.

New England

• Accountable for Novartis business in medical centers in RI and MA.• Products promoted included Diovan, Lotrel, Starlix, Femara, Sandostatin, Exjade, Gleevec.• Areas of responsibility encompassed Fellowship Programs, Grand Round Programs in Cardiology, Nephrology, Endocrinology, Rheumatology, Oncology and Hematology departments.• Developed relationships with KOLs to share clinical experience with Diovan and Lotrel.• Formulary wins for Diovan, Lotrel and Starlix at all RI teaching hospitals.• Diovan and Lotrel 2nd highest DDD market share Area R31 (hospital sales).

Rhode Island

• Sales experience encompassed primary care sales, specialty sales, hospital sales, and managed teaching centers in RI and Southern MA.• Accountable for Wyeth business in Cardiology, Nephrology, Women’s Health, Rheumatology, Oncology, Pathology, Radiology and Hematology.• HMO’s covered included Neighborhood Health, Blue Cross Blue Shield of RI, United Health Plan of RI, RIGHA (Rhode Island Group Health Association).• Exclusive responsibility for Enbrel in Southern New England.• Identified and developed local rheumatology thought leaders to national speakers’ bureau.• Attained highest Enbrel market share in region.